These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 9419428)
1. Antigen-presenting cells and the selection of immunodominant epitopes. Blum JS; Ma C; Kovats S Crit Rev Immunol; 1997; 17(5-6):411-7. PubMed ID: 9419428 [TBL] [Abstract][Full Text] [Related]
2. Role of APC in the selection of immunodominant T cell epitopes. Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031 [TBL] [Abstract][Full Text] [Related]
3. New insights in antigen processing and epitope selection: development of novel immunotherapeutic strategies for cancer, autoimmunity and infectious diseases. Haque A; Blum JS J Biol Regul Homeost Agents; 2005; 19(3-4):93-104. PubMed ID: 16602623 [TBL] [Abstract][Full Text] [Related]
4. The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes. Sant AJ; Chaves FA; Jenks SA; Richards KA; Menges P; Weaver JM; Lazarski CA Immunol Rev; 2005 Oct; 207():261-78. PubMed ID: 16181342 [TBL] [Abstract][Full Text] [Related]
5. Presentation of abundant endogenous class II DR-restricted antigens by DM-negative B cell lines. Kovats S; Whiteley PE; Concannon P; Rudensky AY; Blum JS Eur J Immunol; 1997 Apr; 27(4):1014-21. PubMed ID: 9130658 [TBL] [Abstract][Full Text] [Related]
6. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization. Muczynski KA; Anderson SK; Pious D J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276 [TBL] [Abstract][Full Text] [Related]
7. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589 [TBL] [Abstract][Full Text] [Related]
8. Unexpected reactivities of T cells selected by a single MHC-peptide ligand. Singh N; Van Kaer L J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950 [TBL] [Abstract][Full Text] [Related]
9. Chemical chaperones enhance superantigen and conventional antigen presentation by HLA-DM-deficient as well as HLA-DM-sufficient antigen-presenting cells and enhance IgG2a production in vivo. Ghumman B; Bertram EM; Watts TH J Immunol; 1998 Oct; 161(7):3262-70. PubMed ID: 9759841 [TBL] [Abstract][Full Text] [Related]
10. How HLA-DM works: recognition of MHC II conformational heterogeneity. Sadegh-Nasseri S; Chou CL; Hartman IZ; Kim A; Narayan K Front Biosci (Schol Ed); 2012 Jun; 4(4):1325-32. PubMed ID: 22652874 [TBL] [Abstract][Full Text] [Related]
11. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes. Loyer V; Fontaine P; Pion S; Hétu F; Roy DC; Perreault C J Immunol; 1999 Dec; 163(12):6462-7. PubMed ID: 10586037 [TBL] [Abstract][Full Text] [Related]
12. The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance. Lazarski CA; Chaves FA; Jenks SA; Wu S; Richards KA; Weaver JM; Sant AJ Immunity; 2005 Jul; 23(1):29-40. PubMed ID: 16039577 [TBL] [Abstract][Full Text] [Related]
13. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040 [TBL] [Abstract][Full Text] [Related]
14. Quantitative defect in staphylococcal enterotoxin A binding and presentation by HLA-DM-deficient T2.Ak cells corrected by transfection of HLA-DM genes. Albert LJ; Denzin LK; Ghumman B; Bangia N; Cresswell P; Watts TH Cell Immunol; 1998 Jan; 183(1):42-51. PubMed ID: 9578718 [TBL] [Abstract][Full Text] [Related]
15. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide. Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399 [TBL] [Abstract][Full Text] [Related]
16. DM and DO shape the repertoire of peptide-MHC-class-II complexes. Karlsson L Curr Opin Immunol; 2005 Feb; 17(1):65-70. PubMed ID: 15653313 [TBL] [Abstract][Full Text] [Related]
17. Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1 *01. Jahn-Schmid B; Fischer GF; Bohle B; Faé I; Gadermaier G; Dedic A; Ferreira F; Ebner C J Allergy Clin Immunol; 2005 Feb; 115(2):399-404. PubMed ID: 15696102 [TBL] [Abstract][Full Text] [Related]
18. Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes. Tine JA; Firat H; Payne A; Russo G; Davis SW; Tartaglia J; Lemonnier FA; Demoyen PL; Moingeon P Vaccine; 2005 Jan; 23(8):1085-91. PubMed ID: 15620483 [TBL] [Abstract][Full Text] [Related]
19. DM determines the cryptic and immunodominant fate of T cell epitopes. Nanda NK; Sant AJ J Exp Med; 2000 Sep; 192(6):781-8. PubMed ID: 10993909 [TBL] [Abstract][Full Text] [Related]
20. Selection of immunodominant epitopes during antigen processing is hierarchical. Sadegh-Nasseri S; Kim A Mol Immunol; 2019 Sep; 113():115-119. PubMed ID: 30146122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]